Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Biochimica Et Biophysica Acta|April 13, 2007
Safety issues and prospects for future generations of PPAR modulatorsAnne Rubenstrunk, Rémy Hanf, Dean W Hum, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 25, 2010
Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytesEmilie Lauressergues, Bart Staels, Karine Valeille, et al.
Endocrine Research|January 18, 2003
Function of the transcriptional regulating protein of 132 kDa (TReP-132) on human P450scc gene expressionFlorence Gizard, Mohamed El-Alfy, Yannick Duguay, et al.
Journal of Cardiovascular Pharmacology|January 13, 2004
Lesion progression in apoE-deficient mice: implication of chemokines and effect of the AT1 angiotensin II receptor antagonist irbesartanGeneviève Martin, Frédérique Dol, Anne-Marie Marés, et al.
Molecular Endocrinology (Baltimore, Md.)|August 30, 2008
Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activityRomain Gineste, Audrey Sirvent, Réjane Paumelle, et al.
The Journal of Biological Chemistry|August 20, 2004
The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1cHeidelinde Jakel, Maxime Nowak, Emanuelle Moitrot, et al.
FEBS Letters|May 19, 2004
The farnesoid X receptor induces very low density lipoprotein receptor gene expressionAudrey Sirvent, Thierry Claudel, Geneviève Martin, et al.
Molecular and Cellular Biology|May 19, 2005
TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1Florence Gizard, Romain Robillard, Olivier Barbier, et al.
Pageof 2